microRNA (miRNA) Global Market is Projected to Reach $840.8 Billion by 2030: Increasing Demand for Liquid Biopsies to Drive Growth

Dublin, June 30, 2023 (GLOBE NEWSWIRE) -- The "microRNA (miRNA): Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for microRNA (miRNA) estimated at US$282.6 Million in the year 2022, is projected to reach a revised size of US$840.8 Million by 2030, growing at a CAGR of 14.6% over the analysis period 2022-2030.

Products, one of the segments analyzed in the report, is projected to record 12.9% CAGR and reach US$419.6 Million by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 16.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $120.5 Million, While China is Forecast to Grow at 18.6% CAGR

The microRNA (miRNA) market in the U.S. is estimated at US$120.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$99.9 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Select Competitors (Total 64 Featured) -

• Abcam Plc
• Agilent Technologies, Inc.
• Biodynamics Laboratory Inc.
• BioGenex
• Bio-Rad Laboratories Inc.
• BioVendor - Laboratorni medicina a.s.
• Dharmacon, a Horizon Discovery Group Co.
• F. Hoffmann-La Roche Ltd
• GeneCopoeia, Inc.
• HTG Molecular Diagnostics, Inc.
• Lexogen GmbH
• Meridian Bioscience
• Miltenyi Biotec
• NanoString Technologies, Inc.
• New England Biolabs
• Norgen Biotek Corp
• OriGene Technologies, Inc.
• Promega Corporation
• QIAGEN NV
• Quantabio
• SeqMatic LLC
• Sistemic Scotland Limited
• System Biosciences LLC
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• TriLink BioTechnologies Inc.

Key Attributes:

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• microRNA (miRNA) - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• A Prelude to MicroRNA
• Impact of Covid-19 and a Looming Global Recession
• 2020 Marked as a Year of Disruption & Transformation
• As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
• World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
• COVID-19 Impact on mRNA Market
• Global Market Prospects and Outlook
• Global miRNA Market Set to Witness Rapid Growth
• Disease Diagnostics Segment Leads the Market
• MicroRNAs Likely to Be Instrumental in Disease Diagnosis and Treatment
• Polymerase Chain Reaction (PCR) Dominates the Instruments Category
• Academic and Government Research Institutes Holds the Largest Share
• North America Dominates Global miRNA Market, Asia-Pacific to Witness Steady Growth
• Competition
• Increasing Emphasis on R&D by Players to Boost Market Growth

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Increasing Incidence of Infectious Diseases and Chronic Conditions to Help miRNA Market Gallop Ahead
• Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
• Increasing Application in Cancer Diagnostics as Biomarkers to Drive Market Growth
• Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
• Breakdown of Total Number of Cancer Cases by Region: 2020
• Breakdown of Total Number of Cancer Cases by Type: 2020
• The Future of miRNA-based Cancer Biomarkers
• Consistent Increase in Risks and Threats from Infections Drive Healthy Market Growth
• Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
• Infection Rates of Viruses ((per infected person)) Involved in Outbreaks Worldwide: 2020
• Infectious Diseases Related Mortality High Among Children below 5 Years: Breakdown of Leading Causes of Death in Children below 5 Years (in %)
• MicroRNA Biomarkers Hold Promise for Diagnosis of Infectious Diseases
• Focus on Development of miRNA-based Therapeutics Bodes Well for Market Growth
• Increasing Investments in miRNA to Bolster Market Growth
• Diagnostics and Therapeutics Investments
• Standard Methods Utilized to measure miRNA Biomarkers
• Advancements in Detection Methodologies Focus on Enhancing Sensitivity and Selectivity of miRNA Detection
• Increasing Demand for Liquid Biopsies to Drive the MicroRNA Market
• miRNA by Type of Gastrointestinal Cancers
• Circulating miRNAs as Cancer Detectors
• Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for the Market
• Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
• Growing Global Healthcare Spending and Supportive Government Initiatives Boost Market Prospects
• World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
• Per Capita Healthcare Expenditure (in $) by Select Countries for 2018
• miRNA and Next Generation Sequencing
• Market Restraints
• AN INSIGHT INTO MIRNA APPLICATIONS
• CANCER
• Role of miRNA in Cancer Cell
• DNA Repair and Cancer
• HEART DISEASE
• miRNA-712
• Human Homolog - microRNA-205
• KIDNEY DISEASE
• NERVOUS SYSTEM
• Stroke
• ALCOHOLISM
• OBESITY
• HEMOSTASIS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/qq9f8f

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Global Market for microRNA (miRNA)